JOSE MANUEL RUBIN LOPEZ-rekin lankidetzan egindako argitalpenak (25)

2022

  1. KCNH2 p.Gly262AlafsTer98: A New Threatening Variant Associated with Long QT Syndrome in a Spanish Cohort

    Life, Vol. 12, Núm. 4

2021

  1. The clinical impact of untreated slow ventricular tachycardia in patients carrying implantable cardiac defibrillators

    Journal of Interventional Cardiac Electrophysiology, Vol. 62, Núm. 1, pp. 103-111

2019

  1. Insights for stratification of risk in brugada syndrome

    European Cardiology Review , Vol. 14, Núm. 1, pp. 45-49

  2. Spectral analysis of the QT interval increases the prediction accuracy of clinical variables in Brugada syndrome

    Journal of Clinical Medicine, Vol. 8, Núm. 10

  3. The QT interval dynamic in a human experimental model of controlled heart rate and QRS widening

    Journal of Clinical Medicine, Vol. 8, Núm. 9

2018

  1. Analysis of early failure of Biotronik Linox Smart implantable cardioverter-defibrillator leads: A comparative study of three defibrillator leads

    PACE - Pacing and Clinical Electrophysiology, Vol. 41, Núm. 9, pp. 1165-1170

  2. Delta of the local ventriculo-atrial intervals at the septal location to differentiate tachycardia using septal accessory pathways from atypical atrioventricular nodal re-entry

    Europace, Vol. 20, Núm. 10, pp. 1638-1646

  3. Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing

    Europace, Vol. 20, Núm. FI1, pp. f64-f71

2017

  1. Ablation of Rotor Domains Effectively Modulates Dynamics of Human: Long-Standing Persistent Atrial Fibrillation

    Circulation: Arrhythmia and Electrophysiology, Vol. 10, Núm. 12

  2. Characterization of a stepwise approach in cavotricuspid isthmus ablation for typical atrial flutter: A randomized study comparing three catheters

    PACE - Pacing and Clinical Electrophysiology, Vol. 40, Núm. 10, pp. 1052-1058

  3. Differential methylation of lncRNA KCNQ1OT1 promoter polymorphism was associated with symptomatic cardiac long QT

    Epigenomics, Vol. 9, Núm. 8, pp. 1049-1057

2016

  1. Aleteo auricular atípico y ablación de la conducción transauricular receptor-donante tras trasplante cardiaco ortotópico

    Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1114-1115

  2. Momento del implante de un marcapasos tras el recambio valvular aórtico percutáneo

    Revista Espanola de Cardiologia

  3. Surveillance after cardiac arrest in patients with Brugada syndrome without an implantable defibrillator: An alarm effect of the previous syncope

    International Journal of Cardiology, Vol. 218, pp. 69-74

2015

  1. Long-term evolution of pacemaker dependency after percutaneous aortic valve implantation with the corevalve prosthesis

    International Journal of Cardiology, Vol. 201, pp. 61-63

  2. Time-dependent responses to provocative testing with flecainide in the diagnosis of Brugada syndrome

    Heart Rhythm, Vol. 12, Núm. 2, pp. 350-357

2013

  1. Conduction disorders and transcatheter aortic valve. clinically relevant or just a mild complication?

    Revista Espanola de Cardiologia, Vol. 66, Núm. 9, pp. 692-694

2011

  1. Atrioventricular conduction disturbance characterization in transcatheter aortic valve implantation with the corevalve prosthesis

    Circulation: Cardiovascular Interventions, Vol. 4, Núm. 3, pp. 280-286

  2. Bloqueo intrahisiano durante el implante de la prótesis aórtica percutánea CoreValve

    Revista Espanola de Cardiologia

2010

  1. Espectro mutacional del gen SCN5A en pacientes españoles con síndrome de Brugada

    Revista Espanola de Cardiologia, Vol. 63, Núm. 7, pp. 856-859